نتایج جستجو برای: beta interferon therapy

تعداد نتایج: 880725  

Journal: :Antimicrobial agents and chemotherapy 2007
Masahiko Yano Masanori Ikeda Ken-Ichi Abe Hiromichi Dansako Shogo Ohkoshi Yutaka Aoyagi Nobuyuki Kato

To date, only a limited number of studies have reported finding an influence of ordinary nutrients on hepatitis C virus (HCV) RNA replication. However, the effects of other nutrients on HCV RNA replication remain largely unknown. We recently developed a reporter assay system for genome-length HCV RNA replication in hepatoma-derived HuH-7 cells (OR6). Here, using this OR6 assay system, we compre...

Journal: :hepatitis monthly 0
yue-li xiong department of infectious diseases, institute for viral hepatitis, key laboratory of molecular biology for infectious diseases, ministry of education, second affiliated hospital of chongqing medical university, chongqing, china fen liu department of infectious diseases, institute for viral hepatitis, key laboratory of molecular biology for infectious diseases, ministry of education, second affiliated hospital of chongqing medical university, chongqing, china fen liu department of infectious diseases, institute for viral hepatitis, key laboratory of molecular biology for infectious diseases, ministry of education, second affiliated hospital of chongqing medical university, chongqing, china dazhi zhang department of infectious diseases, institute for viral hepatitis, key laboratory of molecular biology for infectious diseases, ministry of education, second affiliated hospital of chongqing medical university, chongqing, china hong ren department of infectious diseases, institute for viral hepatitis, key laboratory of molecular biology for infectious diseases, ministry of education, second affiliated hospital of chongqing medical university, chongqing, china peng hu department of infectious diseases, institute for viral hepatitis, key laboratory of molecular biology for infectious diseases, ministry of education, second affiliated hospital of chongqing medical university, chongqing, china; department of infectious diseases, institute for viral hepatitis, key laboratory of molecular biology for infectious diseases, ministry of education, second affiliated hospital of chongqing medical university, chongqing, china. tel: +86-2363693289, fax: +86-2363703790

background after treatment cessation, a high prevalence of relapse was reported in chronic hepatitis b (chb) patients in china, especially in nucleot(s)ide analogues (nucs)-experienced patients. re-treatment for these patients remains unsolved. objectives this study aims to evaluate the efficacy of pegylated interferon in hbeag positive patients with exposure to antiviral therapy. patients and ...

Journal: :Archives of neurology 2009
Annie W Chiu Nancy Richert Mary Ehrmantraut Joan Ohayon Shiva Gupta Giuseppe Bomboi Deeya Gaindh Fredric K Cantor Joseph A Frank Henry F McFarland Francesca Bagnato

OBJECTIVES To investigate the heterogeneity in magnetic resonance image (MRI) patterns of response to interferon beta across patients with multiple sclerosis or within an individual patient over time. DESIGN, SETTING, AND PATIENTS Fifteen patients with relapsing-remitting multiple sclerosis underwent monthly MRIs and clinical examinations (6-month pretherapy phase and 36-month therapy phase) ...

Journal: :مجله علوم اعصاب شفای خاتم 0
ayda radfar student research committee, faculty of medicine, mashhad university of medical sciences, mashhad, iran

multiple sclerosis (ms) is an inflammatory disorder, in which neurons in central nervous system (cns) become demyelinated .ms is named for its formation of plaques due to sclerosis of myelin. variable degree of demyelination results in mild, mediate or severe symptomatic episodes of this disease. it is commonly characterized by recurrent relapses and often followed by severe neurological disabi...

Journal: :Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia 2001
M P Pender

Dr Macdonell makes it clear that when considering this therapy one has to take into account the nature of the disease at the time of clinical presentation. Currently it is unclear whether interferon beta is beneficial in secondary progressive MS, and so its initiation at this stage of MS is probably best avoided. Certainly interferon beta should be avoided in primary progressive MS at present, ...

Journal: :Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 2005
Andrea Nicolini Angelo Carpi

Distant metastases from breast cancer are incurable. In endocrine-responsive patients antiestrogens are commonly administered as first and second line therapy. Regrettably, tumor growth becomes resistant to this relatively innocuous therapy. Beta-interferon was unsuccessfully added to tamoxifen to induce estrogen receptor enhancement. In mice, interleukin-2 added to tamoxifen increased their mu...

2015
Kerstin Hansen Katrin Schüssel Marita Kieble Johanna Werning Martin Schulz Robert Friis Dieter Pöhlau Norbert Schmitz Joachim Kugler Sreeram V. Ramagopalan

BACKGROUND Long-term therapies such as disease modifying therapy for Multiple Sclerosis (MS) demand high levels of medication adherence in order to reach acceptable outcomes. The objective of this study was to describe adherence to four disease modifying drugs (DMDs) among statutorily insured patients within two years following treatment initiation. These drugs were interferon beta-1a i.m. (Avo...

Multiple sclerosis (MS) is an inflammatory disorder, in which neurons in central nervous system (CNS) become demyelinated .MS is named for its formation of plaques due to sclerosis of myelin. Variable degree of demyelination results in mild, mediate or severe symptomatic episodes of this disease. It is commonly characterized by recurrent relapses and often followed by severe neurological disabi...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید